[1]
2016. Prediction of the effect of neoadjuvant chemotherapy in patients with non-small cell lung cancer of stage III at phases of combined treatment. Voprosy onkologii. 62, 4 (Dec. 2016), 499–503. DOI:https://doi.org/10.37469/0507-3758-2016-62-4-499-503.